Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phyco-Biotech is a French biotechnology company specializing in the extraction and stabilization of phycocyanin from spirulina. Founded by Luc Lefeuvre, the company utilizes a proprietary cold extraction process to produce high-quality, concentrated liquid phycocyanin for the nutraceutical and dermo-cosmetic markets. Their products are marketed as potent natural antioxidants and immune system boosters, designed to maintain the biological activity of microalgae derivatives without the use of synthetic solvents. Based in the Montpellier region, Phyco-Biotech serves as a key supplier of bioactive algae components for health and wellness applications. The company is recognized for its innovation in preserving the integrity of phycobiliproteins through sustainable and chemical-free methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phyco-Biotech.